Microcirculation, vitamin E and omega 3 fatty acids: an overview
- PMID: 9131193
- DOI: 10.1007/978-1-4899-1792-8_15
Microcirculation, vitamin E and omega 3 fatty acids: an overview
Abstract
We have observed significant increases in LDF and similar trends for CBV after FO supplementation in younger subjects (both normolipidemic and hyperlipidemic). In elderly subjects, this trend appears to be reversed unless subjects are supplemented with higher doses of vit. E (100 IU/10 KG/day). Our mouse data suggest that dietary vit. E at 100 IU/Kg does not adequately protect against lipid oxidation in vivo or in vitro following an oxidative insult when mice are fed an 8% FO & 2% linoleic acid containing diet. It has been reported that FO significantly lowers triglycerides and VLDL-cholesterol (especially where subjects have higher initial triglyceride values) and tends to increase LDL-cholesterol and Apo-B100. These findings are all the more important because the oxidation of LDL from FO-supplemented subjects caused a time-dependent increase in the ability to facilitate albumin transfer which was not diminished following a 2 month washout (WO). Addition of vit. E to the FO supplement prevented this change. These data suggest that FO supplementation without sufficient vit. E may be deleterious to the vascular endothelium. The western fat blend supplement appeared to be protective with increased length of supplementation most likely due to increased MONO fatty acids which are resistant to oxidation; vit. E supplementation appeared to have little additional effect. Our combined studies, and those reported by others, suggest that in humans, increased peripheral microcirculatory flow is most likely due to changes in precapillary vascular tone i.e., vasodilation. It is also possible that subtle changes in each of the three variables i.e. blood pressure, blood viscosity and vascular tone when combined may contribute to the significant changes which we have noted as increased LDF or CBV after intervention with dietary n-3 fatty acids. We hypothesize that interactions between dietary fatty acids and vit. E alters the ratios of vasoconstrictive-platelet aggegatory/vasodilatory-antiplatelet aggregatory agents (TXA2 and endothelin/PGI2 and nitric oxide), the expression of adhesion molecules (P-selectin and E-selectin) and thereby directly influences the modulation of free radical mediated events between blood elements and the vascular endothelium. Fatty acids of the n3 series may alter these events by favoring the production of vasodilatory compounds and decreased expression of P and/or E-selectins, provided that these highly oxidizable lipids are protected by adequate antioxidants.
Similar articles
-
Effects of dietary omega-3 and omega-6 lipids and vitamin E on serum cytokines, lipid mediators and anti-DNA antibodies in a mouse model for rheumatoid arthritis.J Am Coll Nutr. 1999 Dec;18(6):602-13. doi: 10.1080/07315724.1999.10718895. J Am Coll Nutr. 1999. PMID: 10613412
-
Studies on membrane lipid peroxidation in omega-3 fatty acid-fed autoimmune mice: effect of vitamin E supplementation.Adv Exp Med Biol. 1990;262:95-102. doi: 10.1007/978-1-4613-0553-8_8. Adv Exp Med Biol. 1990. PMID: 2321492
-
A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.J Clin Lipidol. 2016 Mar-Apr;10(2):386-93. doi: 10.1016/j.jacl.2015.12.017. Epub 2015 Dec 29. J Clin Lipidol. 2016. PMID: 27055970 Clinical Trial.
-
N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients.Ann N Y Acad Sci. 1993 Jun 14;683:16-34. doi: 10.1111/j.1749-6632.1993.tb35689.x. Ann N Y Acad Sci. 1993. PMID: 8352438 Review.
-
Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing.J Nutr Health Aging. 2004;8(3):163-74. J Nutr Health Aging. 2004. PMID: 15129302 Review.
Cited by
-
The efficacy of vitamin E against oxidative damage and autoantibody production in systemic lupus erythematosus: a preliminary study.Clin Rheumatol. 2007 Mar;26(3):401-4. doi: 10.1007/s10067-006-0477-x. Epub 2006 Dec 2. Clin Rheumatol. 2007. PMID: 17143589 Clinical Trial.
-
Improvement of accommodation with anti-oxidant supplementation in visual display terminal users.J Nutr Health Aging. 2012 May;16(5):478-81. doi: 10.1007/s12603-012-0059-3. J Nutr Health Aging. 2012. PMID: 22555795 Clinical Trial.
-
Immune-modulating enteral formulations: optimum components, appropriate patients, and controversial use of arginine in sepsis.Curr Gastroenterol Rep. 2007 Aug;9(4):329-37. doi: 10.1007/s11894-007-0038-8. Curr Gastroenterol Rep. 2007. PMID: 17883983 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical